A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.

  • Van Der Walt, Anneke (Primary Chief Investigator (PCI))
  • Macdonnell, Richard (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date16/03/2131/12/26


  • Multiple sclerosis (MS)
  • Neurological disorders
  • Clinical trial